Castle Biosciences, Inc. - Common stock — datos financieros trimestrales (NASDAQ:CSTL) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 24.36 M-6.04 M20.82 M22.63 M26.93 M-22.13 M 48.25 M Flujo de caja de las actividades de inversión 5.77 M-22.43 M-28.38 M-18.39 M8.83 M-25.8 M -63.74 M Flujo de caja de las actividades financieras -5.38 M-1.55 M101 K-919 K-4.59 M-5.03 M -10.44 M Flujo de caja libre 24.36 M-6.04 M11.56 M7.8 M19.75 M-34.58 M 4.52 M

Noticias

BTIG rebaja el precio objetivo de Castle Biosciences por mayores costes

Castle Biosciences T1 2026: ingresos superan previsiones y guía revisada al alza

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know